Collagen meniscus implant is a biocompatible scaffold made up of Type I collagen matrix used. The collagen meniscus implant is used to reinforce and repair a meniscus defect, which is the segmental loss of meniscal tissue in the knee, followed by partial meniscectomy. The collagen meniscus implant is inserted in place of the native meniscus through a minimally invasive procedure. Collagen meniscus implant consist of porous cross-linked matrix scaffold that promotes the ingrowth of the body's own cells. The number of patients with meniscal lesions who are undergoing arthroscopic partial meniscectomy is rising significantly, owing to increasing participation of the population in sports.

Market Dynamics

Increasing incidences of meniscal tear, which may lead to arthritis is a major factor that is expected to drive the collagen meniscus implant market growth during the forecast period. According to the American Academy of Physical Medicine and Rehabilitation, July 2017, an estimated 850,000 knee meniscal injury cases are reported annually in the U.S., and around 10% to 20% of orthopedic surgeries involve surgical repair of the meniscus. Moreover, Availability novel implants and presence of key players is expected to propel the market growth over the forecast period. For instance, Active Implants LLC offers NUsurface Meniscus Implant. Moreover, in September 2019, Active Implants LLC received Breakthrough Device Designation from U.S. FDA for its NUsurface Meniscus implant

Key features of the study

• This report provides in-depth analysis of the global collagen meniscus implant market, market size (USD Mn), and compound annual growth rate (CAGR %) over the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles leading players in the global collagen meniscus implant market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Zimmer Biomet Holdings, Inc., RTI Surgical Holdings, Inc., Stryker Corporation, Orthonika, Active Implants LLC, and Biofixth
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
• The global collagen meniscus implant market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global collagen meniscus implant market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• By Age Group
  • Pediatric
  • Adult
• By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Center
• By Regional Insights
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Zimmer Biomet Holdings, Inc.
  • RTI Surgical Holdings, Inc.
  • Stryker Corporation
  • Orthonika
  • Active Implants LLC
  • Biofixt